Patent · US Active

Soluble estradiol capsule for vaginal insertion

US11065197B2 · kind B2 · utility

8Cited by

586References

22Claims

0Family size

Assignee

Compass Therapeutics LLC · US

Inventors

Brian A. Bernick · Boca Raton, US
Julia M. Amadio · Boca Raton, US
Peter H. R. Persicaner · Boca Raton, US
Thorsteinn Thorsteinsson · Boynton Beach, US
Janice Louise Cacace · St. Petersburg, US
Frederick D. Sancilio · North Palm Beach, US
Neda Irani · North Palm Beach, US

Key dates

Filing date	Apr 1, 2020
Grant date	Jul 20, 2021
Priority date	—
Expiry date	Apr 1, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.